Determining Intravenous Complications in Patients with Infusion Pumps

Öz

Objective: Intravenous infusion complications are placing patients at high risk and creating an economic burden for hospitals and health institutions. Available infusion pumps provide to decrease complications and patient safety. However, life-threatening complications may occur in patients with infusion pumps. This study was performed to determine of incidence of intravenous complications and influencing factors in patients with infusion pumps. Method: The study utilized causal model comparison and cross sectional design and was carried out with 120 patients monitored with infusion pump in a single university hospital in Turkey. Independent variables such as patients’ demographic data, catheter type, catheter site, intravenous infusion type, infusion duration, and total infusion volume in patients with infusion pump that influencing complications were investigated in this study. Results: Intravenous infusion complications developed in 10% of patients in present study. Thrombophlebitis 6.7% was the most frequent complication. The study did not reveal any significant difference between the patient's age, gender, number of comorbidities and incidence of intravenous infusion complications p>0.05 . Statistically significant differences were found between the catheter site, infusion duration, total infusion volume and incidence of intravenous infusion complications p

Anahtar Kelimeler

• Intravenous,infusion pump,risk factor,complication,nurse

İnfüzyon pompası ile izlenen hastalarda intravenöz komplikasyonların belirlenmesi

Öz

Amaç: İntravenöz infüzyon komplikasyonları hastaları yüksek risk altında bırakarak, hastaneler ve sağlık kuruluşları için ekonomik yük oluşturmaktadır. Mevcut infüzyon pompaları, komplikasyonları azaltmakta ve hasta güvenliğini sağlamaktadır. Buna rağmen, infüzyon pompası ile takip edilen hastalarda sağlığı tehdit edici komplikasyonlar gelişebilmektedir. Bu araştırma infüzyon pompası ile izlenen hastalarda gelişen komplikasyon sıklığını ve etkileyen faktörleri belirlemek amacıyla yapılmıştır. Yöntem: Nedensel karşılaştırma modeli ve kesitsel tasarımın kullanıldığı bu araştırma, Türkiye’de bulunan bir üniversite hastanesinde, infüzyon pompası ile izlenen 120 hastayla gerçekleştirilmiştir. Çalışmada infüzyon pompası ile izlenen hastaların demografik verileri, kateter tipi, katater bölgesi, intravenöz infüzyon tipi, infüzyon süresi ve toplam infüzyon hacmi gibi bağımsız değişkenlerin infüzyon komplikasyonu gelişme sıklığına etkisi incelenmiştir. Bulgular: Araştırmada hastaların %10`unda infüzyon komplikasyonu gelişmiştir. Tromboflebit %6,7 en sık gelişen komplikasyon olmuştur. Hastaların yaşı, cinsiyeti, eşlik eden komorbid hastalık sayısı ile intravenöz infüzyon komplikasyon sıklığı arasında istatistiksel açıdan anlamlı bir fark bulunmamıştır p>0,05 . Kateter bölgesi, infüzyon süresi, total infüzyon hacmi ile intravenoz infüzyon komplikasyonu arasında anlamlı bir fark olduğu belirlenmiştir p

Anahtar Kelimeler

• İntravenöz,infüzyon pompa,risk faktör,komplikasyon,hemşire

Kaynakça

1. Trbovich PL, Jeon J, Easty A. Smart medication delivery systems: Infusion Pumps. Toronto, ON, Canada: University Health Network 2009; 11-13.
2. Bowcutt M, Rosenkoetter MM, Chernecky CC, Wall J, Wynn D, Serrano C. Implementation of an intravenous medication infusion pump system: implications for nursing. J Nurs Manag 2008;16(2):188-197.
3. Dougherty L, Lamb J. Intravenous therapy in nursing practice: USA: Blackwell Publishing Inc, 2009; 3-21.
4. Cicolini G, Bonghi AP, Di Labio L, Di Mascio R. Position of peripheral venous cannulae and the incidence of thrombophlebitis: an observational study. J Adv Nurs 2009;65(6):1268-1273.
5. Çelik Z, Anıl C. İntravenöz uygulama komplikasyonları. Güncel Gastroloji 2004;8(2):158-164.
6. Salgueiro-Oliveira A, Parreira P, Veiga P. Incidence of phlebitis in patients with peripheral intravenous catheters: The Influence of some risk factors. Aust j Adv Nurs 2012;30(2):32.
7. Saini R, Agnihotri M, Gupta A, Walia I. Epidemiology of infiltration and phlebitis. Nursing and Midwifery Research Journal 2011;7(1):22-33.
8. Macklin D. Phlebitis: A painful complication of peripheral IV catheterization that may be prevented. Am J Nurs 2003;103(2):55-60.

9. Barker P, Anderson A, MacFie J. Randomised clinical trial of elective re-siting of intravenous cannulae. Ann R Coll Surg Engl 2004;86(4):281.
10. Uslusoy E, Mete S. Predisposing factors to phlebitis in patients with peripheral intravenous catheters: a descriptive study. J Am Acad Nurse Pract 2008;20(4):172-180.
11. Santell JP, Cousins DD. Medication errors involving wrong administration technique. Jt Comm J Qual Patient Saf 2005;31(9):528-532.
12. Turple J, MacKinnon NJ, Davis B. Frequency and type of medication discrepancies in one tertiary care hospital. Healthcare Q 2006;(9 Supplement):119-123.
13. Kaur P, Thakur R, Kaur S, Bhalla A. Assessment of risk factors of phlebitis amongst intravenous cannulated patients. Nursing and Midwifery Research 2011;7(3):106-114.
14. Neopane A. Peripheral venous thrombophlebitis risk and the role of hand washing. Nepal Journal of Medical Sciences 2013;2(1):26-29.
15. Abdul-Hak CK, Barros ÂF. The incidence of phlebitis in a medical clinical unit. Texto & Contexto-Enfermagem 2014;22(Aug):1-6.
16. Ovayolu N, Güner İC, Karadağ G. Santral venöz kateter (SVK) uygulanan hastalarda uygulama öncesi ve sonrası alınan önlemlerin belirlenmesi. Anadolu Hemşirelik ve Sağlık Bilimleri Dergisi 2006;9(3):26-35.
17. Aygun G. Damar içi kateter enfeksiyonlarının önlenmesi ve kontrolü. İÜ Cerrahpaşa Tıp Fakültesi Sürekli Tıp Eğitimi Etkinlikleri, Hastane Enfeksiyonları Korunma ve Kontrol Sempozyum Dizisi 2008;60:79-88.
18. White SA. Peripheral intravenous therapy-related phlebitis rates in an adult population. J Infus Nurs 2001;24(1):19-24.
19. Curran E, Coia J, Gilmour H, McNamee S, Hood J. Multi-centre research surveillance project to reduce infections/phlebitis associated with peripheral vascular catheters. J Hosp Infect 2000;46(3):194-202.
20. Furtado LCdR. Incidence and predisposing factors of phlebitis in a surgery department. Br J Nurs 2011;20(Sup7): 16- 25.
21. Nassaji-Zavareh M, Ghorbani R. Peripheral intravenous catheter-related phlebitis and related risk factors. Singapore Med J 2007;48(8):733-736.
22. Cornely OA, Bethe U, Pauls R, Waldschmidt D. Peripheral Teflon catheters: factors determining incidence of phlebitis and duration of cannulation. Infect Control 2002;23(05):249-253.
23. Powell J, Tarnow KG, Perucca R. The relationship between peripheral intravenous catheter indwell time and the incidence of phlebitis. J Infus Nurs 2008;31(1):39-45.
24. Tagalakis V, Kahn SR, Libman M, Blostein M. The epidemiology of peripheral vein infusion thrombophlebitis: a critical review. Am J Med 2002;113(2):146-151.
25. Myles P, Buckland M, Burnett W. Single versus double occlusive dressing technique to minimize infusion thrombophlebitis: Vialon and Teflon cannulae reassessed. Anaesth Intensive Care 1991;19(4):525-529.
26. Regueiro PM, Souto RB, Iglesias MM, Outón FI, Cambeiro NJ, Pértega DS, Pita FS. Peripheral venous catheters: incidence of phlebitis and its determining factors. Rev Enferm 2005;28(10):21-28.
27. Infusion Nurses Society. Infusion-related complication. J Infus Nurs 2006;29(Supplement 1): 58-59.
28. Rothschild JM, Keohane CA, Cook EF, Orav EJ, Burdick E, Thompson S, Hayes J, Bates D. A controlled trial of smart infusion pumps to improve medication safety in critically ill patients. Critical Care Medicine 2005;33 (3):533-540.
29. Bomberg B, Hurley PE, Clark CA, and McLaughlin CS. Complications associated with the use of an infusion pump during knee arthroscopy. Arthroscopy 1992;8(2):224-228.
30. Rauck R, Deer T, Rosen S, Padda G, Barsa J, Dunbar E, Dwarakanath G. Long‐term follow‐up of a novel implantable programmable infusion pump. Neuromodulation: Technology at the Neural Interface 2013;16(2):163-167.
31. Ross PL, Milburn J, Reith DM, Wiltshire E, Wheeler BJ. Clinical review: insulin pump-associated adverse events in adults and children. Acta Diabetologica 2015; 52(6):1017-1024.